032300 — Korea Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Korea Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6,368	-1,119	83.8	3,792	-2,640
Depreciation
Amortisation
Non-Cash Items	1,054	8,899	7,707	5,009	5,326
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,607	-1,881	-5,785	-3,552	-3,165
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,192	8,279	4,819	8,046	2,687
Capital Expenditures	-3,450	-2,752	-2,677	-3,802	-1,332
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-9,458	-49,124	47,576	-8,534	-6,447
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-12,908	-51,875	44,899	-12,335	-7,779
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	45,363	-4,563	-16,661	-15,296	10,732
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	39,675	-48,150	33,034	-19,516	5,621